A new trading day began on Friday, with ATAI Life Sciences N.V (NASDAQ: ATAI) stock price down -4.58% from the previous day of trading, before settling in for the closing price of $1.53. ATAI’s price has ranged from $1.03 to $2.57 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -13.20%. Meanwhile, its annual earnings per share averaged 23.00%. With a float of $136.19 million, this company’s outstanding shares have now reached $167.82 million.
Let’s determine the extent of company efficiency that accounts for 54 employees. In terms of profitability, gross margin is 46.43%, operating margin of -33305.52%, and the pretax margin is -48272.08%.
ATAI Life Sciences N.V (ATAI) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ATAI Life Sciences N.V is 31.83%, while institutional ownership is 7.18%. The most recent insider transaction that took place on Mar 21 ’25, was worth 65,560. In this transaction Chief Business Officer of this company sold 48,563 shares at a rate of $1.35, taking the stock ownership to the 115,636 shares. Before that another transaction happened on Mar 21 ’25, when Company’s Chief Medical Officer sold 11,563 for $1.35, making the entire transaction worth $15,610. This insider now owns 8,437 shares in total.
ATAI Life Sciences N.V (ATAI) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 23.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.72% during the next five years compared to 18.62% growth over the previous five years of trading.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
Here are ATAI Life Sciences N.V’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 883.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.79 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Looking closely at ATAI Life Sciences N.V (NASDAQ: ATAI), its last 5-days average volume was 1.61 million, which is a drop from its year-to-date volume of 2.62 million. As of the previous 9 days, the stock’s Stochastic %D was 81.95%. Additionally, its Average True Range was 0.13.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 21.91%, which indicates a significant decrease from 75.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.91% in the past 14 days, which was lower than the 105.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5402, while its 200-day Moving Average is $1.4408. However, in the short run, ATAI Life Sciences N.V’s stock first resistance to watch stands at $1.5300. Second resistance stands at $1.6000. The third major resistance level sits at $1.6600. If the price goes on to break the first support level at $1.4000, it is likely to go to the next support level at $1.3400. Should the price break the second support level, the third support level stands at $1.2700.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
With a market capitalization of 291.70 million, the company has a total of 199,795K Shares Outstanding. Currently, annual sales are 310 K while annual income is -149,270 K. The company’s previous quarter sales were 40 K while its latest quarter income was -26,290 K.
